Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Factor V Leiden mutation
|
46 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.100 | 0.970 | 33 | 1999 | 2019 | ||||||
Venous Thromboembolism
|
408 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.100 | 1.000 | 15 | 1999 | 2019 | ||||||
Thrombophilia
|
43 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.100 | 1.000 | 12 | 1999 | 2010 | ||||||
Deep Vein Thrombosis
|
93 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.090 | 1.000 | 9 | 1999 | 2018 | ||||||
Coronary Artery Disease
|
1577 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 1.000 | 4 | 2002 | 2009 | ||||||
Coronary heart disease
|
1178 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 0.750 | 4 | 2002 | 2010 | ||||||
Hyperhomocysteinemia
|
45 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 1.000 | 4 | 1999 | 2013 | ||||||
Miscarriage
|
56 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 1.000 | 4 | 2002 | 2016 | ||||||
Portal Vein Thrombosis
|
8 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 1.000 | 4 | 1999 | 2015 | ||||||
Protein C Deficiency
|
14 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 1.000 | 4 | 1999 | 2017 | ||||||
Prothrombin G20210A mutation
|
9 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 0.750 | 4 | 1999 | 2018 | ||||||
prothrombin gene mutation
|
5 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.040 | 1.000 | 4 | 1998 | 2012 | ||||||
Behcet Syndrome
|
243 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.030 | 1.000 | 3 | 2000 | 2013 | ||||||
Cerebrovascular accident
|
591 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.030 | 1.000 | 3 | 1999 | 2016 | ||||||
Ischemic stroke
|
704 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.030 | 0.667 | 3 | 1999 | 2005 | ||||||
Protein S Deficiency
|
14 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.030 | 1.000 | 3 | 2003 | 2017 | ||||||
Activated Protein C Resistance
|
30 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 1996 | 2018 | ||||||
Acute lymphocytic leukemia
|
222 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 1999 | 2018 | ||||||
Acute myocardial infarction
|
118 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 2010 | 2011 | ||||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 1999 | 2018 | ||||||
Anemia, Sickle Cell
|
138 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 2006 | 2013 | ||||||
Antithrombin III Deficiency
|
52 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 2000 | 2017 | ||||||
Cerebral Infarction
|
123 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 2003 | 2009 | ||||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 1.000 | 2 | 1999 | 2018 | ||||||
Coronary Arteriosclerosis
|
440 | 0.547 | 0.720 | 11 | 46739084 | missense variant | G/A;C | snv | 0.020 | 0.500 | 2 | 2004 | 2009 |